News
Adjuvant osimertinib extends DFS in localized NSCLC
Osimertinib reduced the risk of disease recurrence or death by 79% in patients with EGFR-mutated non–small cell lung cancer.
News
Most endometrial cancers treated with minimally invasive procedures
Minimally invasive procedures are recommended for most patients with endometrial cancers, and cancer centers seem to be complying.
News
When to treat, delay, or omit breast cancer therapy in the face of COVID-19
Two groups have released recommendations for treating breast cancer patients during the pandemic.
News
Case fatality rate for COVID-19 near 1.4%, increases with age
“These early estimates give an indication of the fatality ratio across the spectrum of COVID-19 disease and show a strong age gradient in risk of...